Novartis AG
Methods for treating ocular surface pain
Last updated:
Abstract:
The present invention provides methods for treating ocular surface pain by administering 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile (compound I). The present invention also provides methods for treating dry eye disease and ocular hyperemia by administering 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile.
Status:
Grant
Type:
Utility
Filling date:
8 Apr 2021
Issue date:
1 Feb 2022